Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

11.06

+0.24 (2.22%)

At close: Feb 11, 2026, 4:00 PM EST

11.07

+0.01 (0.09%)

After-hours: Feb 11, 2026, 4:32 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Endosomal Escape Vehicle Therapeutics	210.78M
Endosomal Escape Vehicle Therapeutics Growth	63.38%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.